Hypericin and Hyperforin: The Science Behind St John’s Wort and Why June Is the Moment to Find It

St John’s Wort flowers at midsummer. Not as a rough approximation, not as a general seasonal guide — it actually flowers close to St John’s Day on 24th June, the date from which it takes its name. That piece of folk botany is accurate to within a week or two, and it has been observed and recorded across Europe for over a thousand years. Right now, in the third week of June, the first plants are opening. By the solstice, the meadow edges, dry roadsides, and chalk downland of England will be lit up with it.

It is also — and this is worth saying plainly at the outset — one of the most pharmacologically well-studied plants in the world. Not just well-studied for an herb. Well-studied, full stop. There are more randomised controlled trials on Hypericum perforatum for mild-to-moderate depression than on some licensed pharmaceutical antidepressants. The compounds responsible — hypericin and hyperforin — have been the subject of thousands of peer-reviewed papers. Today we are going to look at what the science actually says, what these compounds do, and why this is one of the most significant wild plants you can identify right now.

Identification: how to find it, and how to be certain

There are several yellow-flowered plants that could briefly confuse a new forager in June — ragwort, silverweed, tormentil, agrimony — but St John’s Wort has a specific combination of features that make it unmistakeable once you know what to look for. The identification process should involve at least three of the following features together before you harvest.

• Five bright yellow petals with tiny black glandular dots along the petal margins — these dots contain hypericin and are one of the most reliable ID features
• The crush test: squeeze a flower bud or petal between your fingers — it produces a distinctive blood-red or deep purple stain. This is hypericin. Nothing else in the British flora does this
• Translucent leaf dots: hold a leaf up to the light — you will see tiny pale translucent dots scattered across it. These are oil glands. This feature gives the plant its species name perforatum (perforated). They look like tiny holes
• Two-lined stem: H. perforatum has a distinctive stem with two raised longitudinal ridges running along it. Run your thumbnail along it — you can feel them clearly
• Opposite leaves: small, oval, stalkless, clasping the stem in pairs
• Habitat: dry grassland, roadsides, woodland edges, chalk downland, hedge banks — prefers well-drained, sunny spots
• Height: 30–90cm, erect, branching near the top into a flat-topped cluster of flowers

The red-staining crush test is the single most useful field confirmation. No other common British plant produces a blood-red pigment from its flowers when squeezed. If you are uncertain, do this before harvesting. The June foraging guide has St John’s Wort listed as a peak-season find alongside elderflower and meadowsweet.

Hypericin: the red compound

Hypericin is a naphthodianthrone — a type of polycyclic aromatic compound — and it is responsible for both the red staining of the crush test and many of the plant’s medicinal properties. It is synthesised in the dark glands visible as black dots on the petals and, to a lesser extent, in the translucent glands in the leaves. The concentration is highest in the flowering tops, which is why the harvest window — peak bloom, just before the solstice — matters.

A 2024 documentary analysis published in Pharmaceuticals (PMC11728764) provides a current summary of the evidence: hypericin demonstrates antidepressant activity via multiple mechanisms, including inhibition of monoamine oxidase (MAO) enzymes — the same target as older classes of antidepressant drugs — as well as effects on serotonin, dopamine, and norepinephrine signalling. It also shows documented antiviral activity, including against enveloped viruses, and anti-inflammatory effects via suppression of pro-inflammatory cytokines.

The photosensitivity risk associated with St John’s Wort comes directly from hypericin: it is a photosensitiser, meaning it can make skin more reactive to UV light when taken in sufficient quantities internally. This is relevant to safety (see note below) but also illustrates something important: these are not gentle, inert plant pigments. They are biologically active molecules with measurable pharmacological effects. That is precisely what makes this plant worth understanding.

Hyperforin: the compound doing most of the antidepressant work

For most of the 20th century, hypericin was assumed to be the primary active compound in St John’s Wort. More recent research has shifted that understanding significantly. A 2019 review in Frontiers in Pharmacology (PMC6741737) makes the case clearly: hyperforin — a phloroglucinol derivative found in the translucent glands of the leaves and flowers — is now considered the primary compound responsible for the antidepressant activity observed in clinical trials.

The mechanism is distinct from conventional antidepressants. Rather than selectively inhibiting the reuptake of a single neurotransmitter (as SSRIs do with serotonin), hyperforin inhibits the uptake of serotonin, dopamine, norepinephrine, GABA, and glutamate simultaneously — via activation of TRPC6 ion channels, a mechanism not shared by any pharmaceutical antidepressant. Clinical trials using extracts standardised to different hyperforin concentrations have confirmed that higher hyperforin content produces greater antidepressant effect, establishing it as the key active principle.

Hyperforin is also the compound responsible for most of the known drug interactions (see safety note below) — it induces CYP3A4 liver enzymes, which accelerates the metabolism of many medications. This is the reason St John’s Wort must be treated as a serious pharmacological agent and not a harmless herbal tea.

What the clinical trials actually show

The clinical evidence for St John’s Wort in mild-to-moderate depression is, by herbal medicine standards, unusually robust. A 2016 systematic review in the Journal of Affective Disorders (PMC5010734) analysed 35 randomised controlled trials involving 6,993 patients. The findings:

• Hypericum extracts were significantly superior to placebo in patients with mild-to-moderate major depression
• Response rates were comparable to standard antidepressants (SSRIs and tricyclics)
• Discontinuation rates due to side effects were significantly lower than for pharmaceutical antidepressants
• The evidence is specifically for mild-to-moderate depression — evidence for severe depression is not established

A 2022 review in Nutrients (PMC9587902) adds nuance: the variability between trials is partly explained by differences in extract standardisation. Extracts standardised to both hypericin and hyperforin content perform more consistently than those standardised to hypericin alone. This is a useful reminder that ‘St John’s Wort’ as a commercial supplement varies considerably — the evidence applies to standardised extracts, not to random dried herb capsules or homemade preparations.

The anti-inflammatory picture is also compelling. A 2020 review in Biomolecules (PMC7662691) documented significant suppression of TNF-α, IL-1β, IL-6, and NF-κB activity — the core inflammatory cytokines implicated in both chronic depression and a wide range of inflammatory conditions. The link between inflammation and depression is one of the most active areas of current psychiatric research, and St John’s Wort sits at an interesting intersection of both.

How to use St John’s Wort — and what the evidence supports

St John’s Wort oil (topical use). This is the safest, most accessible use and has a strong evidence base for topical application. Pack a jar loosely with freshly wilted flowers — leave them to wilt for a day after picking to reduce water content, which prevents mould. Cover completely with olive oil. Seal and place on a sunny windowsill. Over 4–6 weeks the oil turns deep crimson-red as hypericin is extracted. Strain, bottle, and use within a year. The colour is extraordinary. Evidence supports topical use for nerve pain, bruising, minor burns, and wound healing. This is not a contested claim — it is well-documented in the pharmacological literature.

St John’s Wort tea (mild, occasional). Pour just-boiled water over a small handful of fresh flowering tops. Steep 5–7 minutes. The tea is mildly bitter with a faint floral note. For occasional use as a calming tea, the risk profile is low for healthy adults not on medication. Do not use regularly or in quantity without reading the safety note below.

Internal medicinal use. The clinical evidence applies to standardised pharmaceutical-grade extracts — not to fresh plant preparations. If you are considering St John’s Wort for depression or anxiety, the evidence supports discussing this with your GP, who can prescribe or recommend an extract with known hypericin and hyperforin content, check for drug interactions, and monitor appropriately. The foraging context here is botanical knowledge and cultural history — not a protocol for self-treatment.

St John’s Wort and the midsummer calendar

There is something worth pausing on here. This plant is named for a saint’s day. It flowers at the solstice with a consistency that made it a reliable seasonal marker for pre-industrial communities across Europe. It was hung above doors on Midsummer’s Eve to ward off evil spirits — a piece of folklore that, when you know about its documented antiviral and antimicrobial properties, reads less like superstition and more like pre-scientific empiricism. The red oil was used by medieval herbalists as a wound treatment. The wound-healing evidence is now peer-reviewed.

This is the pattern that keeps appearing in foraging science: that traditional plant knowledge, when examined carefully, turns out to have a functional basis. It does not always. But with St John’s Wort, the overlap between folk use and evidence-based pharmacology is unusually close. The meadowsweet post on salicylates made a similar case — the pattern of traditional anti-inflammatory herbs holding up under clinical scrutiny is one of the most consistently interesting stories in this space.

References

• PMC11728764 — Documentary Analysis of Hypericum perforatum (St John’s Wort). Pharmaceuticals. 2024.
• PMC6741737 — Role of Hyperforin in the Pharmacological Activities of St John’s Wort. Front Pharmacol. 2019.
• PMC5010734 — A Systematic Review of St John’s Wort for Major Depressive Disorder. J Affect Disord. 2016.
• PMC9587902 — Advantages and Disadvantages of Using St John’s Wort as a Treatment for Depression. Nutrients. 2022.
• PMC7662691 — Protective Role of St John’s Wort and Its Components on the Inflammatory Pathway. Biomolecules. 2020.
• PMC4939296 — Neuroprotective Activity of Hypericum perforatum and Its Major Components. Front Plant Sci. 2016.

A note on safety

This content is for educational purposes only and does not constitute medical advice. St John’s Wort is a potent herb and is not safe for everyone. It is a known inducer of CYP3A4 liver enzymes and P-glycoprotein, which means it can significantly reduce the effectiveness of many prescription medications — including contraceptive pills, anticoagulants (warfarin), antiretroviral drugs, immunosuppressants (cyclosporin), some antidepressants, and digoxin. Do not take St John’s Wort medicinally if you are on any prescription medication without first consulting your GP. It may cause photosensitivity — avoid prolonged sun exposure when taking it internally. Do not use during pregnancy or breastfeeding. This post covers the science of the plant’s bioactive compounds for educational purposes only — it is not a recommendation to self-treat depression or any other condition. Always consult your GP for mental health concerns.